These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone. Remington G; Mamo D; Labelle A; Reiss J; Shammi C; Mannaert E; Mann S; Kapur S Am J Psychiatry; 2006 Mar; 163(3):396-401. PubMed ID: 16513859 [TBL] [Abstract][Full Text] [Related]
23. Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia. Paquet F; Soucy JP; Stip E; Lévesque M; Elie A; Bédard MA J Neuropsychiatry Clin Neurosci; 2004; 16(1):47-56. PubMed ID: 14990759 [TBL] [Abstract][Full Text] [Related]
28. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia. Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897 [TBL] [Abstract][Full Text] [Related]
29. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride. Kegeles LS; Slifstein M; Frankle WG; Xu X; Hackett E; Bae SA; Gonzales R; Kim JH; Alvarez B; Gil R; Laruelle M; Abi-Dargham A Neuropsychopharmacology; 2008 Dec; 33(13):3111-25. PubMed ID: 18418366 [TBL] [Abstract][Full Text] [Related]
30. Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia. de Haan L; Booij J; Lavalaye J; van Amelsvoort T; Linszen D Psychopharmacology (Berl); 2006 Jan; 183(4):500-5. PubMed ID: 16292589 [TBL] [Abstract][Full Text] [Related]
31. Olanzapine for schizophrenia. Med Lett Drugs Ther; 1997 Jan; 39(992):5-6. PubMed ID: 9008682 [No Abstract] [Full Text] [Related]
34. Dissolution profile, tolerability, and acceptability of the orally disintegrating olanzapine tablet in patients with schizophrenia. Chue P; Jones B; Taylor CC; Dickson R Can J Psychiatry; 2002 Oct; 47(8):771-4. PubMed ID: 12420656 [TBL] [Abstract][Full Text] [Related]
35. Typical antipsychotic drugs -- D(2) receptor occupancy and depressive symptoms in schizophrenia. Bressan RA; Costa DC; Jones HM; Ell PJ; Pilowsky LS Schizophr Res; 2002 Jul; 56(1-2):31-6. PubMed ID: 12084417 [TBL] [Abstract][Full Text] [Related]
36. Dopamine D2 receptor occupancy by risperidone: implications for the timing and magnitude of clinical response. Catafau AM; Corripio I; Pérez V; Martin JC; Schotte A; Carrió I; Alvarez E Psychiatry Res; 2006 Dec; 148(2-3):175-83. PubMed ID: 17059881 [TBL] [Abstract][Full Text] [Related]
37. Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study. Meisenzahl EM; Schmitt G; Gründer G; Dresel S; Frodl T; la Fougère C; Scheuerecker J; Schwarz M; Boerner R; Stauss J; Hahn K; Möller HJ Pharmacopsychiatry; 2008 Sep; 41(5):169-75. PubMed ID: 18763218 [TBL] [Abstract][Full Text] [Related]
38. [Mnestic impairment under olanzapine overdosage in an elderly patient]. Grieshaber S; Jatzko A; Adler G Psychiatr Prax; 2002 Nov; 29(8):441-4. PubMed ID: 12436366 [TBL] [Abstract][Full Text] [Related]
39. A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia. Ikai S; Remington G; Suzuki T; Takeuchi H; Tsuboi T; Den R; Hirano J; Tsunoda K; Nishimoto M; Watanabe K; Mimura M; Mamo D; Uchida H J Clin Psychiatry; 2012 Aug; 73(8):1147-52. PubMed ID: 22967779 [TBL] [Abstract][Full Text] [Related]